Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts

By Reusser Pierre  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1745-1753

Informa Healthcare

Access to resources Recommend Favorite

Drug Targets in Cytomegalovirus Infection

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 2, 2009-04 ,pp. : 201-222

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Drug Discovery for New Anti-Pneumocystis Compounds

By  

Current Medicinal Chemistry, Vol. 16, Iss. 20, 2009-07 ,pp. : 2514-2530

Bentham Science Publishers

Access to resources Recommend Favorite

Planar Bioadhesive Microdevices: A New Technology for Oral Drug Delivery

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 7, 2014-07 ,pp. : 673-683

Bentham Science Publishers

Access to resources Recommend Favorite

Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host

By Freeman Richard B  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 2007-2016

Informa Healthcare

Access to resources Recommend Favorite